Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma-Reference-Cited by-同舟云学术

Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma

Published:2008-02-19 Issue:5 Volume:98 Page:931-940
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Campbell L,Jasani B,Edwards K,Gumbleton M,Griffiths D F R

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6604243.pdf

Reference62 articles.

1. Altomare DA, Testa JR (2005) Pertubations of the AKT signalling pathway in human cancer. Oncogene 24: 7455–7464

2. Asano T, Yao Y, Zhu J, Li D, Abbruzzese JL, Reddy SA (2005) The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation. Biochem Biophys Res Commun 331: 295–302

3. Averous J, Proud CG (2006) When translation meets transformation: the mTOR story. Oncogene 25: 6423–6435

4. Campbell L, Gumbleton M, Griffiths DFR (2003) Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. Br J Cancer 89: 1909–1913

5. Carman CV, Lisanti MP, Benovic JL (1999) Regulation of G protein-coupled receptor kinases by caveolin. J Biol Chem 274: 8858–8864

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Caveolin Gene Expression Predicts Clinical Outcomes for Early-Stage HER2-Negative Breast Cancer Treated with Paclitaxel-Based Chemotherapy in the GeparSepto Trial;Clinical Cancer Research;2023-07-11

2. Caveolin-1 Regulates Cellular Metabolism: A Potential Therapeutic Target in Kidney Disease;Frontiers in Pharmacology;2021-12-10

3. Bladder Cancer Invasion Is Mediated by Mammalian Target of Rapamycin Complex 2–Driven Regulation of Nitric Oxide and Invadopodia Formation;The American Journal of Pathology;2021-12

4. Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma;Frontiers in Oncology;2021-04-28

5. Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?;Cancers;2021-04-03